| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,089,697 |
|
|
Indirect Shares
|
264,473 |
|
|
| Direct
Value |
$8,309,557 |
|
|
|
Indirect Value
|
$120,004 |
|
|
| Total
Shares |
1,354,170 |
|
|
| Total
Value |
$8,429,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
372 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-11-28 |
4 |
B |
$5.40 |
$540,000 |
D/D |
100,000 |
407,304 |
2.39 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-05-18 |
4 |
A |
$1.90 |
$47,500 |
D/D |
25,000 |
408,324 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-11-10 |
4 |
S |
$58.50 |
$1,170,700 |
I/I |
(20,000) |
408,842 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-06-04 |
4 |
OE |
$3.48 |
$87,000 |
D/D |
25,000 |
425,876 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2012-02-21 |
4 |
B |
$6.12 |
$122,400 |
D/D |
20,000 |
427,304 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-11-09 |
4 |
S |
$58.50 |
$526,500 |
I/I |
(9,000) |
428,842 |
|
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-06-21 |
4 |
B |
$2.00 |
$100,000 |
D/D |
50,000 |
430,724 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-07-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,346 |
434,669 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-08-09 |
4 |
S |
$38.68 |
$619,080 |
D/D |
(16,000) |
434,669 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,588 |
436,257 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-08-24 |
4 |
S |
$58.00 |
$1,160,924 |
I/I |
(20,000) |
437,842 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-05-21 |
4 |
A |
$1.94 |
$58,470 |
D/D |
30,000 |
438,324 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-05-25 |
4 |
A |
$2.05 |
$10,250 |
D/D |
5,000 |
443,324 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-05-29 |
4 |
A |
$2.01 |
$1,005 |
D/D |
500 |
443,824 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-05-31 |
4 |
A |
$2.05 |
$1,025 |
D/D |
500 |
444,324 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-06-01 |
4 |
A |
$2.05 |
$2,665 |
D/D |
1,300 |
445,624 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-06-05 |
4 |
A |
$2.05 |
$2,460 |
D/D |
1,200 |
446,824 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2012-02-23 |
4 |
B |
$5.91 |
$59,100 |
D/D |
10,000 |
447,304 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-08-09 |
4 |
OE |
$5.97 |
$95,520 |
D/D |
16,000 |
450,669 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-06-07 |
4 |
A |
$2.00 |
$9,234 |
D/D |
4,611 |
451,435 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-03-13 |
4 |
OE |
$6.25 |
$100,000 |
D/D |
16,000 |
452,257 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-07-25 |
4 |
S |
$59.37 |
$59,370 |
I/I |
(1,000) |
457,842 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-05-03 |
4 |
S |
$46.54 |
$698,100 |
I/I |
(15,000) |
462,542 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-06-08 |
4 |
A |
$2.04 |
$30,257 |
D/D |
14,803 |
466,238 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2018-06-11 |
4 |
A |
$2.04 |
$11,229 |
D/D |
5,480 |
471,718 |
0 |
- |
|
372 Records found
|
|
Page 13 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
